As the biomarker-directed treatment landscape continues to evolve in advanced gastric and gastroesophageal junction (G/GEJ) adenocarcinomas, clinicians must navigate a growing array of biomarker testing results and treatment options, including several immune checkpoint inhibitors, to personalize therapy choices. In this immersive case, test your ability to translate biomarker findings into immunotherapy-based treatment plans and manage immune-related toxicities to optimize outcomes. In this interactive Clinical Case Challenge, you will: Apply biomarker testing guidelines Evaluate guideline recommendations to guide immunotherapy use in advanced G/GEJ adenocarcinoma Identify and manage immune-related adverse events to maintain safety and treatment continuity.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Case study / clinical scenario
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedDec 5, 2025
-
Last day to claim creditDec 5, 2026 8 weeks left
-
PRIME Education, Inc. (PRIME®) Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care
-
PRIME Education, Inc. (PRIME®) The Biomarker Puzzle: Choosing and Managing Targeted Treatment Approaches in Advanced G/GEJ Adenocarcinoma
-
PRIME Education, Inc. (PRIME®) Immunity in Balance: Navigating Immune-Related Adverse Event Management With Checkpoint Inhibitors in Advanced Upper GI Adenocarcinomas
